MedPath

Stugeron Forte

Brand Name: Stugeron Forte

Generic Name: Cinnarizine

Active
Registration Number

DR-XY40786

Dosage Form

Capsule

Issuance Date

April 19, 2022

Expiry Date

March 26, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength75 mg
PackagingClear PVC-Alu blister pack x 10's/Box of 100's

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-vertigo preparations
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

CinnarizineActive
Monograph: Cinnarizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform